California State Teachers Retirement System (CalSTRS)’s Aimmune Therapeutics AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-70,264
Closed -$2.42M 3100
2020
Q3
$2.42M Buy
70,264
+157
+0.2% +$3.34K ﹤0.01% 1394
2020
Q2
$1.17M Buy
70,107
+2,139
+3% +$36.3K ﹤0.01% 1777
2020
Q1
$980K Sell
67,968
-768
-1% -$19.6K ﹤0.01% 1691
2019
Q4
$2.3M Sell
68,736
-494
-0.7% -$13.8K ﹤0.01% 1483
2019
Q3
$1.45M Buy
69,230
+827
+1% +$16.9K ﹤0.01% 1720
2019
Q2
$1.42M Buy
68,403
+886
+1% +$18.2K ﹤0.01% 1760
2019
Q1
$1.51M Sell
67,517
-1,000
-1% -$23.5K ﹤0.01% 1699
2018
Q4
$1.64M Buy
68,517
+2,269
+3% +$58.7K ﹤0.01% 1604
2018
Q3
$1.81M Sell
66,248
-24
-0% -$679 ﹤0.01% 1693
2018
Q2
$1.78M Buy
66,272
+12,127
+22% +$371K ﹤0.01% 1693
2018
Q1
$1.72M Sell
54,145
-1,325
-2% -$46.6K ﹤0.01% 1626
2017
Q4
$2.1M Sell
55,470
-1,127
-2% -$36.4K ﹤0.01% 1538
2017
Q3
$1.4M Sell
56,597
-5,718
-9% -$123K ﹤0.01% 1802
2017
Q2
$1.28M Buy
62,315
+10,500
+20% +$200K ﹤0.01% 1892
2017
Q1
$1.13M Sell
51,815
-2,400
-4% -$49.2K ﹤0.01% 2013
2016
Q4
$1.11M Sell
54,215
-1,300
-2% -$26.6K ﹤0.01% 2040
2016
Q3
$833K Buy
55,515
+400
+0.7% +$5.4K ﹤0.01% 2190
2016
Q2
$596K Buy
55,115
+31,555
+134% +$429K ﹤0.01% 2356
2016
Q1
$319K Buy
23,560
+2,967
+14% +$46.3K ﹤0.01% 2665
2015
Q4
$380K Buy
20,593
+293
+1% +$5.42K ﹤0.01% 2596
2015
Q3
$514K Buy
+20,300
New +$475K ﹤0.01% 2405

California State Teachers Retirement System (CalSTRS)'s AIMT Position: Q4 2020 in Review

California State Teachers Retirement System (CalSTRS) sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 70,264 shares — an estimated $2.42M sold.

California State Teachers Retirement System (CalSTRS) first reported a position in AIMT in Q3 2015 and held it in 21 quarters. The position peaked at $2.42M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 70,264 Aimmune Therapeutics shares in Q4 2020, an estimated $2.42M.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Aimmune Therapeutics in Q3 2015 and held it in 21 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Aimmune Therapeutics position peaked at $2.42M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q4 2020, filed 16 Feb 2021.